Parameters of blood short-chain peptides and digestive hydrolases in patients with chronic hepatitis B virus infection

The aim of the study was to examine specifics of changes in the level of stomach- and pancreas-released blood hydrolases in chronic viral hepatitis B and analyze the mechanisms underlying such changes. We assessed serum markers of HBV infection, liver enzymes tests as well as gastric and pancreatic...

Full description

Bibliographic Details
Main Authors: M. A. Zhuraeva, V. A. Aleinik, N. D. Ashuralieva, D. S. Halikova, J. B. Ravzatov, B. K. Abdulazizhozhyv
Format: Article
Language:Russian
Published: Sankt-Peterburg : NIIÈM imeni Pastera 2021-11-01
Series:Инфекция и иммунитет
Subjects:
Online Access:https://www.iimmun.ru/iimm/article/view/1393
_version_ 1797971199236505600
author M. A. Zhuraeva
V. A. Aleinik
N. D. Ashuralieva
D. S. Halikova
J. B. Ravzatov
B. K. Abdulazizhozhyv
author_facet M. A. Zhuraeva
V. A. Aleinik
N. D. Ashuralieva
D. S. Halikova
J. B. Ravzatov
B. K. Abdulazizhozhyv
author_sort M. A. Zhuraeva
collection DOAJ
description The aim of the study was to examine specifics of changes in the level of stomach- and pancreas-released blood hydrolases in chronic viral hepatitis B and analyze the mechanisms underlying such changes. We assessed serum markers of HBV infection, liver enzymes tests as well as gastric and pancreatic hydrolase level. The patients examined were divided into three groups: control (healthy) and two study groups — HBV post-infection and chronic HBV infection. Patients with HBV post-infection had no significant deviations from normal range for blood level of gastric and pancreatic hydrolases. Patients with chronic HBV infection were found to contain increased blood level of amylase and lipase, which may evidence about increasing pancreatic functional activity and development of covert pancreatitis. At the same time, decline in the concentration of serum pepsinogen-1 below 40 μg/l could indicate about prominently decreased secretion of hydrochloric acid and development of atrophic gastritis, and it was found that the major factor contributing to development of such disorders was the short-chain peptide CCK-8, which utilization declines in patients with chronic HBV infection. CCK-8 can play a pivotal role in inhibiting stimulation of gastric acid secretion and controls gastric acid, plasma gastrin and somatostatin secretion. Cholecystokinin has been found to inhibit acid secretion by activating CCK type A receptors as well as via somatostatin-involving mechanism. The secretion of gastric somatostatin-14 increased by fivefold due to CCK-8 alone, but was blocked by the CCK-A receptor blocker loxiglumide. These data show that CCK-8 directly inhibits acid reactions by stimulating the release of gastric somatostatin indirectly through the CCK-A receptor. Thus, it can be assumed that normally CCK-8 is mainly utilized by the liver, which is altered during chronic hepatitis B resulting in elevated blood CCK-8 concentration. As a consequence, it enhances pancreatic secretion resulting in developing pancreatitis that is paralleled with inhibited gastric secretion and emerged atrophic gastritis.
first_indexed 2024-04-11T03:28:51Z
format Article
id doaj.art-3ee903a6817246a1929282d508d419e3
institution Directory Open Access Journal
issn 2220-7619
2313-7398
language Russian
last_indexed 2024-04-11T03:28:51Z
publishDate 2021-11-01
publisher Sankt-Peterburg : NIIÈM imeni Pastera
record_format Article
series Инфекция и иммунитет
spelling doaj.art-3ee903a6817246a1929282d508d419e32023-01-02T06:40:31ZrusSankt-Peterburg : NIIÈM imeni PasteraИнфекция и иммунитет2220-76192313-73982021-11-0111597397810.15789/2220-7619-POB-13931029Parameters of blood short-chain peptides and digestive hydrolases in patients with chronic hepatitis B virus infectionM. A. Zhuraeva0V. A. Aleinik1N. D. Ashuralieva2D. S. Halikova3J. B. Ravzatov4B. K. Abdulazizhozhyv5Andijan State Medical InstituteAndijan State Medical InstituteAndijan State Medical InstituteAndijan State Medical InstituteAndijan State Medical InstituteAndijan State Medical InstituteThe aim of the study was to examine specifics of changes in the level of stomach- and pancreas-released blood hydrolases in chronic viral hepatitis B and analyze the mechanisms underlying such changes. We assessed serum markers of HBV infection, liver enzymes tests as well as gastric and pancreatic hydrolase level. The patients examined were divided into three groups: control (healthy) and two study groups — HBV post-infection and chronic HBV infection. Patients with HBV post-infection had no significant deviations from normal range for blood level of gastric and pancreatic hydrolases. Patients with chronic HBV infection were found to contain increased blood level of amylase and lipase, which may evidence about increasing pancreatic functional activity and development of covert pancreatitis. At the same time, decline in the concentration of serum pepsinogen-1 below 40 μg/l could indicate about prominently decreased secretion of hydrochloric acid and development of atrophic gastritis, and it was found that the major factor contributing to development of such disorders was the short-chain peptide CCK-8, which utilization declines in patients with chronic HBV infection. CCK-8 can play a pivotal role in inhibiting stimulation of gastric acid secretion and controls gastric acid, plasma gastrin and somatostatin secretion. Cholecystokinin has been found to inhibit acid secretion by activating CCK type A receptors as well as via somatostatin-involving mechanism. The secretion of gastric somatostatin-14 increased by fivefold due to CCK-8 alone, but was blocked by the CCK-A receptor blocker loxiglumide. These data show that CCK-8 directly inhibits acid reactions by stimulating the release of gastric somatostatin indirectly through the CCK-A receptor. Thus, it can be assumed that normally CCK-8 is mainly utilized by the liver, which is altered during chronic hepatitis B resulting in elevated blood CCK-8 concentration. As a consequence, it enhances pancreatic secretion resulting in developing pancreatitis that is paralleled with inhibited gastric secretion and emerged atrophic gastritis.https://www.iimmun.ru/iimm/article/view/1393chronic hepatitis bserum gastric hydrolasespancreatic serum hydrolasespancreatitisatrophic gastritis
spellingShingle M. A. Zhuraeva
V. A. Aleinik
N. D. Ashuralieva
D. S. Halikova
J. B. Ravzatov
B. K. Abdulazizhozhyv
Parameters of blood short-chain peptides and digestive hydrolases in patients with chronic hepatitis B virus infection
Инфекция и иммунитет
chronic hepatitis b
serum gastric hydrolases
pancreatic serum hydrolases
pancreatitis
atrophic gastritis
title Parameters of blood short-chain peptides and digestive hydrolases in patients with chronic hepatitis B virus infection
title_full Parameters of blood short-chain peptides and digestive hydrolases in patients with chronic hepatitis B virus infection
title_fullStr Parameters of blood short-chain peptides and digestive hydrolases in patients with chronic hepatitis B virus infection
title_full_unstemmed Parameters of blood short-chain peptides and digestive hydrolases in patients with chronic hepatitis B virus infection
title_short Parameters of blood short-chain peptides and digestive hydrolases in patients with chronic hepatitis B virus infection
title_sort parameters of blood short chain peptides and digestive hydrolases in patients with chronic hepatitis b virus infection
topic chronic hepatitis b
serum gastric hydrolases
pancreatic serum hydrolases
pancreatitis
atrophic gastritis
url https://www.iimmun.ru/iimm/article/view/1393
work_keys_str_mv AT mazhuraeva parametersofbloodshortchainpeptidesanddigestivehydrolasesinpatientswithchronichepatitisbvirusinfection
AT vaaleinik parametersofbloodshortchainpeptidesanddigestivehydrolasesinpatientswithchronichepatitisbvirusinfection
AT ndashuralieva parametersofbloodshortchainpeptidesanddigestivehydrolasesinpatientswithchronichepatitisbvirusinfection
AT dshalikova parametersofbloodshortchainpeptidesanddigestivehydrolasesinpatientswithchronichepatitisbvirusinfection
AT jbravzatov parametersofbloodshortchainpeptidesanddigestivehydrolasesinpatientswithchronichepatitisbvirusinfection
AT bkabdulazizhozhyv parametersofbloodshortchainpeptidesanddigestivehydrolasesinpatientswithchronichepatitisbvirusinfection